WB

William Blair Latest Price Targets & Analyst Ratings

Stock Analyst Price Price Target Upside
Downside
Rating Date
NIQ
1
NIQ Global Intelligence plc
NIQ
$4.99B
KM
Kevin Mcveigh
$16.90 $24
42%
upside
Outperform 17 days ago
RARE icon
2
Ultragenyx Pharmaceutical
RARE
$3.01B
SC
Sami Corwin
$31.28 $65
108%
upside
Outperform 3 months ago
PLTR icon
3
Palantir
PLTR
$370B
LD
Louie DiPalma
$156.14 $84
46%
downside
Market Perform 6 months ago
SLDB icon
4
Solid Biosciences
SLDB
$433M
TL
Tim Lugo
$5.56 $40
619%
upside
Outperform 1 year ago
ARCT icon
5
Arcturus Therapeutics
ARCT
$455M
MM
Myles Minter
$16.76 $71
324%
upside
Outperform 2 years ago
TARS icon
6
Tarsus Pharmaceuticals
TARS
$2.42B
$57.43 $44
23%
downside
Outperform 2 years ago
CRSP icon
7
CRISPR Therapeutics
CRSP
$4.8B
SC
Sami Corwin
$52.74 $75
42%
upside
Outperform 2 years ago
ONON icon
8
On Holding
ONON
$15B
SP
Sam Poser
$46.05 $26
44%
downside
Sell 2 years ago
VFC icon
9
VF Corp
VFC
$5.85B
SP
Sam Poser
$14.97 $27
80%
upside
Buy 2 years ago
UAA icon
10
Under Armour
UAA
$2.26B
SP
Sam Poser
$5.26 $11
109%
upside
Buy 2 years ago
FL icon
11
Foot Locker
FL
$2.3B
SP
Sam Poser
$24.10 $29
20%
upside
Hold 3 years ago
QURE icon
12
uniQure
QURE
$973M
SC
Sami Corwin
$17.73 $66
272%
upside
Outperform 3 years ago
SKX icon
13
Skechers
SKX
$9.5B
$63.23 $51
19%
downside
Buy 3 years ago
TSHA icon
14
Taysha Gene Therapies
TSHA
$889M
RP
Raju Prasad
$3.26 $46
1,311%
upside
Outperform 4 years ago
BEAM icon
15
Beam Therapeutics
BEAM
$1.88B
$18.54 $33
78%
upside
Outperform 5 years ago
NBIX icon
16
Neurocrine Biosciences
NBIX
$13.9B
MM
Myles Minter
$140.40 $116
17%
downside
Outperform 5 years ago